BR9910405A - Fenilssulfonamida-feniletilaminas úteis como receptores de dopamina - Google Patents

Fenilssulfonamida-feniletilaminas úteis como receptores de dopamina

Info

Publication number
BR9910405A
BR9910405A BR9910405-9A BR9910405A BR9910405A BR 9910405 A BR9910405 A BR 9910405A BR 9910405 A BR9910405 A BR 9910405A BR 9910405 A BR9910405 A BR 9910405A
Authority
BR
Brazil
Prior art keywords
useful
dopamine receptors
phenylethylamines
phenylsulfonamide
alkyl
Prior art date
Application number
BR9910405-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Arthur Glenn Romero
Jeffrey A Leiby
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BR9910405A publication Critical patent/BR9910405A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46Y being a hydrogen or a carbon atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9910405-9A 1998-05-14 1999-05-07 Fenilssulfonamida-feniletilaminas úteis como receptores de dopamina BR9910405A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8549398P 1998-05-14 1998-05-14
PCT/US1999/007023 WO1999058499A1 (en) 1998-05-14 1999-05-07 Phenylsulfonamide-phenylethylamines useful as dopamine receptors

Publications (1)

Publication Number Publication Date
BR9910405A true BR9910405A (pt) 2001-01-09

Family

ID=22191975

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9910405-9A BR9910405A (pt) 1998-05-14 1999-05-07 Fenilssulfonamida-feniletilaminas úteis como receptores de dopamina

Country Status (24)

Country Link
US (1) US6103766A (enExample)
EP (1) EP1077935B1 (enExample)
JP (1) JP2002514623A (enExample)
KR (1) KR20010043546A (enExample)
CN (1) CN1152857C (enExample)
AT (1) ATE253045T1 (enExample)
AU (1) AU752543B2 (enExample)
BR (1) BR9910405A (enExample)
CA (1) CA2327345A1 (enExample)
DE (1) DE69912419T2 (enExample)
DK (1) DK1077935T3 (enExample)
EA (1) EA002918B1 (enExample)
ES (1) ES2211078T3 (enExample)
HU (1) HUP0101746A3 (enExample)
IL (1) IL139263A0 (enExample)
NO (1) NO20005732D0 (enExample)
NZ (1) NZ508152A (enExample)
PL (1) PL343891A1 (enExample)
PT (1) PT1077935E (enExample)
SK (1) SK16242000A3 (enExample)
TR (1) TR200003325T2 (enExample)
TW (1) TW450954B (enExample)
WO (1) WO1999058499A1 (enExample)
ZA (1) ZA200005921B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT971878E (pt) * 1997-02-27 2008-07-08 Takeda Pharmaceutical Compostos de amina, sua produção e utilização como inibidores da produção de amilóide beta
JP2005508852A (ja) * 2001-05-07 2005-04-07 スミスクライン・ビーチャム・コーポレイション スルホンアミド
WO2002089785A1 (en) * 2001-05-07 2002-11-14 Smithkline Beecham Corporation Sulfonamides
ATE520659T1 (de) 2004-10-14 2011-09-15 Abbott Gmbh & Co Kg Zur behandlung von auf die modulation des dopamin-d3-rezeptors ansprechenden erkrankungen geeignete azabicycloheptylverbindungen
CA2583918C (en) * 2004-10-14 2013-01-29 Abbott Gmbh & Co. Kg Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
DE602005027382D1 (de) 2004-10-14 2011-05-19 Abbott Gmbh & Co Kg Zur behandlung von auf eine modulation des dopamin-d3-rezeptors ansprechende erkrankungen geeignete heterocyclische verbindungen
TWI400233B (zh) * 2006-04-14 2013-07-01 Abbott Gmbh & Co Kg 適用於治療對多巴胺d3受體之調節有反應的疾病之芳氧基乙胺化合物
CA2648543C (en) * 2006-04-14 2015-06-02 Abbott Gmbh & Co. Kg Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
JP2009534355A (ja) 2006-04-19 2009-09-24 アボット ゲーエムベーハー ウント カンパニー カーゲー セロトニン5ht6受容体の調節に応答する障害を治療するために好適な複素環化合物
MX2008013434A (es) 2006-04-19 2009-01-26 Abbott Gmbh & Co Kg Arilsufonas heterociclicas adecuadas para tratar trastornos que responden a la modulacion del receptor de serotonina 5ht6.
WO2008026046A1 (en) * 2006-08-30 2008-03-06 Pfizer Products Inc. Morpholine d3 dopamine antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574741A (en) * 1969-04-14 1971-04-13 Mead Johnson & Co Sulfonamidophenalkylamines
US5451677A (en) * 1993-02-09 1995-09-19 Merck & Co., Inc. Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
GB9402197D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Compounds
CN1088062C (zh) * 1994-11-23 2002-07-24 纽罗根公司 某些4-氨基甲基-2-取代的咪唑衍生物2-氨基甲基-4-取代的咪唑衍生物新的一族多巴胺受体亚型特异性配体
EP0917530B1 (en) * 1996-05-11 2003-02-19 SmithKline Beecham plc Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
US5922770A (en) * 1996-07-22 1999-07-13 Novo Nordisk A/S Compounds with growth hormone releasing properties
JPH1180156A (ja) * 1997-09-04 1999-03-26 Hokuriku Seiyaku Co Ltd 1−(置換アリール)アルキル−1h−イミダゾピリジン−4−アミン誘導体

Also Published As

Publication number Publication date
HUP0101746A2 (hu) 2002-03-28
NZ508152A (en) 2003-03-28
TW450954B (en) 2001-08-21
PT1077935E (pt) 2004-03-31
SK16242000A3 (sk) 2001-06-11
AU752543B2 (en) 2002-09-19
NO20005732L (no) 2000-11-13
WO1999058499A1 (en) 1999-11-18
TR200003325T2 (tr) 2001-04-20
DE69912419D1 (de) 2003-12-04
PL343891A1 (en) 2001-09-10
EA200001184A1 (ru) 2001-04-23
NO20005732D0 (no) 2000-11-13
EP1077935A1 (en) 2001-02-28
KR20010043546A (ko) 2001-05-25
ES2211078T3 (es) 2004-07-01
EA002918B1 (ru) 2002-10-31
JP2002514623A (ja) 2002-05-21
IL139263A0 (en) 2001-11-25
HUP0101746A3 (en) 2002-10-28
CN1297431A (zh) 2001-05-30
EP1077935B1 (en) 2003-10-29
US6103766A (en) 2000-08-15
ZA200005921B (en) 2001-11-14
HK1036049A1 (en) 2001-12-21
ATE253045T1 (de) 2003-11-15
DK1077935T3 (da) 2004-02-16
DE69912419T2 (de) 2004-07-22
CA2327345A1 (en) 1999-11-18
CN1152857C (zh) 2004-06-09
AU3741899A (en) 1999-11-29

Similar Documents

Publication Publication Date Title
BR0014733A (pt) Derivados éter biarìlico úteis como inibidores de recaptação de monoamina
BR9910405A (pt) Fenilssulfonamida-feniletilaminas úteis como receptores de dopamina
ECSP066520A (es) Derivados de dihidrobenzofuranilo alcanamina y métodos para su uso
BR0012951A (pt) Agonistas de retinóides seletivos
BR0011542A (pt) Compostos de fenoxipropilamina
NO943526L (no) Kinuklidin-derivater som substans P antagonister
ES2175161T3 (es) Derivados de piperazina como antagonistas de taquiquinina.
CR7510A (es) DERIVADOS DE [1-4] DIAZEPINO[6,7,1-iJ)] QUINOLONA COMO AGENTES ANTIPSICOTICOS Y CONTRA LA OBESIDAD
BR9908470A (pt) Composto, composição farmacêutica, e, processo para tratar condições mediadas pela inegrina avb3 em um mamìfero em necessidade de tal tratamento
PE20010205A1 (es) Derivados 3-sustituido de 2-carboxiciclopropil glicina como agonistas de glutamato
BR0115291A (pt) Derivados de 2-fenilaminoimidazolina fenil cetona substituìdos como antagonistas de ip
BR9909253A (pt) Derivados de 2-ariletil-(piperidin-4-ilmetil) amina como antagonistas de receptor muscarìnico
DK0923542T3 (da) Arylsubstituerede cycliske aminer som selektive dopamin-D3-ligander
BR0110247A (pt) Derivado de ciclohexilamina como antagonistas de receptor de nmda seletivos em subtipo
BR0007229A (pt) Aminoazaciclos heterocìclicos substituìdos úteis como agentes de sistema nervoso central
BR0103210A (pt) Derivados de azabicicloalcano e suas utilizações terapêuticas
ECSP088398A (es) Compuestos tricíclicos útiles como agonistas de receptores de oxitocina
BR0013582A (pt) Agonistas retinóides seletivos para rar
BR0014712A (pt) Uso de derivados carbonilamino contra distúrbios do snc
ES2182509T3 (es) Derivados de n-ariloxietilamina para el tratamiento de la depresion.
BRPI0409180A (pt) compostos de pirrol[1,2-b]piridazina e seus usos como antagonistas do receptor cfr-1
EA200001058A1 (ru) Новые способы лечения нервных расстройств
ES2141134T3 (es) Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares.
BR0208508A (pt) Derivados de ciclopropilindol como inibidores seletivos da captação de serotonina
DE69811487D1 (de) Benzoesäurederivate und deren medizinische verwendung

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL.8: C07C 311/21, C07C 311/29, C07C 311/44, A61K 31/18, A61K 31/63, A61P 25/16, A61P 25/18, A61P 25/22, A61P 25/24, A61P 25/00

Ipc: C07C 311/21 (2007.10), C07C 311/29 (2007.10), C07C

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.